News Summary

Biotech entrepreneur Collin Gage, cofounder and CEO of ARMR Sciences, is leading efforts to develop a vaccine aimed at preventing deaths from fentanyl overdoses. The company is initiating a trial to test the vaccine in humans, marking a significant stride in combating the opioid crisis. Fentanyl, a synthetic opioid, is a major contributor to overdose deaths in the United States. Gage’s initiative seeks to provide preventative protection against this lethal drug, as current treatments like naloxone are reactionary. The vaccine represents a new paradigm in overdose prevention, aligning with renewed interest in opioid vaccines amid the ongoing epidemic.